The White House announced Thursday it has reached an agreement with drug manufacturers as part of the Biden administration's effort to negotiate Medicare prescription drug prices. President Joe Biden ...

Biden-era policies have reined in insulin prices for Medicare patients, a new study says. Roughly three out of four (75%) Medicare prescription beneficiaries were paying $35 or less for each month's ...

President Joe Biden delivered his second State of the Union address and heard directly from House Republicans during his speech who jeered several of his proposals. This was the first time Biden ...

(CNN) — Medicare’s new power to negotiate drug prices will lead to an estimated $6 billion in savings for the federal government and a $1.5 billion reduction in out-of-pocket costs for seniors when ...

Coverage of high-cost drugs selected for Medicare price negotiation has improved under the Inflation Reduction Act, according to an analysis from KFF. All Medicare Part D enrollees now have coverage ...

The Inflation Reduction Act, best known for Medicare drug-price negotiation, also contained provisions that capped out-of-pocket prescription drug costs. After the implementation of these provisions, ...

WASHINGTON — When President Joe Biden suggested that Republicans want to slash Medicare and Social Security, the GOP howls of protest during his State of the Union address showcased a striking ...

(The Hill) – The Centers for Medicare and Medicaid (CMS) announced Friday it will not be finalizing a rule proposed by the Biden administration that would have allowed Medicare and Medicaid ...

President Biden has said he doesn’t support “Medicare for all,” citing the program’s high price tag of $32 trillion. But by reopening Affordable Care Act enrollment on Feb. 15, boosting ACA subsidies ...

The Gazette offers audio versions of articles using Instaread. Some words may be mispronounced. A recent letter to the editor (Aug 22, “Miller-Meeks should stick to her knitting) claimed a “gotcha” on ...

Drug-related provisions of a landmark Biden-era law were tied to a decline in cost-related medication nonadherence among Medicare enrollees in their first year in the program, a quasi-experimental ...